Company: IMRX
Filing Date: 2025-04-21
Form Type: DEF 14A
Source: 0001790340-25-000053
Chunk: 28

Company: Immuneering Corp
Filing Date: 2025-04-21
Form: DEF 14A
Chunk 28
---
 and evaluating our peer group composition. The compensation committee evaluated whether any of the work performed by Radford during 2024 raised any conflict of interest and determined that it did not.

#### Nominating and Corporate Governance Committee
Our nominating and corporate governance committee is responsible for, among other things:

• identifying individuals qualified to become members of our Board of Directors;

• recommending to our Board of Directors the persons to be nominated for election as directors and to each committee of the Board;

• developing and recommending to our Board of Directors corporate governance guidelines, and reviewing and recommending to our Board proposed changes to our corporate governance guidelines from time to time; and

• overseeing a periodic evaluation of our Board of Directors.

Our nominating and corporate governance committee currently consists of Ann E. Berman, Peter Feinberg, and Diana F. Hausman, M.D., with Dr. Hausman serving as chair. Our Board of Directors has determined that each of Ms. Berman, Mr. Feinberg, and Dr. Hausman qualifies as independent under the applicable Nasdaq rules.

Board of Directors and Committee Meetings and Attendance

During the year ended December 31, 2024, our Board of Directors met six times, the audit committee met five times, the compensation committee met five times, and the nominating and corporate governance committee met twice. Each of the incumbent directors attended at least 75% of the total of the meetings of the Board of directors and the committees on which he or she served as a member during the year ended December 31, 2024.

#### Executive Sessions
Executive sessions, which are meetings of the non-management members of the Board of Directors, are regularly scheduled throughout the year. In addition, at least twice a year, the independent directors meet in a private session that excludes management and any non-independent directors. At each of these meetings, the non-management and independent directors in attendance, as applicable, determine which member will preside at such session.

Director Attendance at Annual Meeting of Stockholders

We do not have a formal policy regarding the attendance of members of our Board of Directors at our annual meetings of stockholders, but we expect all directors to make every effort to attend any meeting of stockholders. Six of our seven then-incumbent directors attended our 2024 annual meeting of stockholders.

#### Director Nominations Process
The nominating and corporate governance committee is responsible for recommending candidates to serve on our Board of Directors and its committees. In considering whether to recommend any particular candidate to serve on the